OD tablets T20 containing S-1 Taiho, from Okayama Taiho Pharmaceutical (YJ code: 4229101F1050, standard: 20mg x 1 tablet (equivalent to tegafur)), is a combination chemotherapy drug with tegafur, gimeracil, and oteracil potassium. It is prescribed for various advanced cancers, including gastric, colorectal, pancreatic, and head and neck cancers, aiming to boost antitumor effects and mitigate gastrointestinal toxicities.
OD tablets T20 containing S-1 Taiho
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
